Sosei Heptares and Kallyope collaborate to identify gastrointestinal GPCR targets May 17, 2022 Sosei and Kallyope have entered a strategic research collaboration to identify and validate novel G protein-coupled receptor (GPCR) targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases.Read More
Osivax collaborates with NIAID to combine OVX-836 with NIAID influenza vaccine candidates May 17, 2022
SOM signs licensing agreement with University of Minnesota to support muscular dystrophy work May 16, 2022
NexImmune, Yale and JDRF partner to explore AIM nanoparticles with teplizumab for type 1 diabetes May 11, 2022
Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs May 6, 2022
RSS